Condition: Hypertension · Dyslipidemias · Type 2 Diabetes · Sponsor: Duke University
This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.
This description comes directly from the study's public registry record.
Stuart T Carr, BA · 919 668-4849 · stuart.carr@duke.edu
Charles Muiruri, PhD · 919 660-3212 · charles.muiruri@duke.edu
Always discuss trial participation with your own doctor first.
| Duke University - Charlotte Study Sites | Charlotte, North Carolina, United States | Recruiting |
| Duke University - Duke Study Site | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05129345